Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RU79073
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
RU79073 is a small molecule compound classified as a hydroquinoline derivative and chemically known as 1,2,3,4-tetrahydroquinolin-8-yl dihydrogen phosphate. It has been used primarily as a research tool or fragment in drug discovery and structural biology studies. There is no evidence of clinical development or therapeutic use for any specific disease. Its mechanism of action and biological targets are not well characterized in the literature[1][2][3][4].
- Other names
- 1,2,3,4-tetrahydroquinolin-8-yl dihydrogen phosphateFragment 12Fragment12Fragment-121o4fAC1NR9W0AC-1NR9W0AC 1NR9W0CHEMBL358860CHEMBL-358860CHEMBL 358860BDBM14682BDBM-14682BDBM 14682DB03525DB-03525DB 035251,2,3,4-tetrahydroquinolin-8-yloxyphosphonic acid(1,2,3,4-tetrahydroquinolin-8-yloxy)phosphonic acid
Beyond the preview
Go deeper on RU79073.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RU79073.